EMAD IBRAHIM ABABNEH, MBBS

COLUMBUS, OH

Research Active
Pathology - Anatomic Pathology & Clinical Pathology NPI registered 8+ years 8 publications 2017 – 2024 NPI: 1962996496

Practice Location

3535 OLENTANGY RIVER RD
COLUMBUS, OH 43214-3908

Phone: (614) 566-4945

What does EMAD ABABNEH research?

Dr. Ababneh studies Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features, a type of thyroid tumor that is often uncertain in terms of whether it is cancerous. He examines how doctors diagnose and manage these tumors, as many patients may not need aggressive treatments. His work involves looking at patient outcomes after different types of treatment, such as partial thyroid removal, to determine the best monitoring and care practices for these patients.

Key findings

  • In a study of 319 thyroid tumors diagnosed as NIFTP, there were no cases of tumor recurrence or metastasis over a 3-year follow-up period.
  • The research highlights that current treatment guidelines for NIFTP are often inconsistent and overly aggressive.
  • Patients who underwent partial thyroid removal and received minimal follow-up care still showed no signs of tumor recurrence.

Frequently asked questions

Does Dr. Ababneh study thyroid cancer?
Yes, Dr. Ababneh focuses on thyroid tumors, particularly Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features, which is a type of thyroid tumor with uncertain cancer potential.
What treatments has Dr. Ababneh researched?
He has researched approaches like partial thyroid removal and how these treatments impact patient outcomes over time.
Is Dr. Ababneh's work relevant to patients with thyroid tumors?
Absolutely, his studies provide important insights into the diagnosis and management of thyroid tumors, helping to guide treatment decisions for patients.

Publications in plain English

Case 20-2024: A 73-Year-Old Man with Recurrent Fever and Liver Lesions.

2024

The New England journal of medicine

Ganapathi L, Cochran RL, Robbins GK, Barmettler S, Holland SM +1 more

PubMed

The current state of sinonasal malignancies and recent management updates.

2023

Cancer cytopathology

Ababneh EI, Faquin WC

PubMed

A Comprehensive Study on the Diagnosis and Management of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.

2023

Thyroid : official journal of the American Thyroid Association

Alzumaili BA, Krumeich LN, Collins R, Kravchenko T, Ababneh EI +8 more

Plain English
Researchers studied a type of thyroid tumor called noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) to better understand its diagnosis and treatment. They found that NIFTP rarely led to cancer recurrence after surgery, but the way it was diagnosed often varied, leading to uncertainty in treatment decisions. This highlights the need for clearer guidelines for managing these borderline tumors, which can help doctors take more consistent and effective actions for their patients.

PubMed

Oro- and Nasopharyngeal Papillomas with Squamous and Respiratory Features: A Case Series of Schneiderian-Like Papillomas of the Pharynx.

2022

Head and neck pathology

Ababneh EI, Shah AA

Plain English
This study looked at a specific type of growth called papillomas located in the mouth and throat, which share features with a similar papilloma found in the nasal area. Researchers reviewed 13 cases from 2010 to 2020, finding that 85% of these papillomas were associated with low-risk HPV, while none had high-risk HPV. While most of these tumors looked benign, two cases were linked to invasive squamous cell carcinoma, indicating that even benign growths can sometimes lead to more serious cancers. Who this helps: Patients with papillomas in the throat and doctors treating these conditions.

PubMed

Calciphylaxis in uraemic and nonuraemic settings: clinical risk factors and histopathological findings.

2022

Clinical and experimental dermatology

Ababneh EI, Hassanein M, Saad AM, Cook EE, Ko JS +4 more

Plain English
In this study, researchers looked at a serious skin condition called calciphylaxis, comparing cases in patients with kidney disease and those with normally functioning kidneys. They found that 40% of the cases involved patients without kidney disease, often affecting obese women after menopause, with a notable 44% showing high levels of parathyroid hormone. This research highlights the need for better awareness and diagnosis of calciphylaxis in non-kidney disease patients, as it may be more common than previously thought. Who this helps: This information helps doctors in identifying and treating patients at risk of calciphylaxis, especially those who are postmenopausal and overweight.

PubMed

Case report: Successful simultaneous heart-kidney transplantation across a positive complement-dependent cytotoxic crossmatch.

2022

Frontiers in nephrology

Yamamoto T, Pearson DS, Ababneh EI, Harris C, Nissaisorakarn P +6 more

Plain English
This research examined the outcomes of a patient who received a simultaneous heart and kidney transplant from a donor that typically would be rejected due to the presence of specific antibodies. Despite the high risks usually associated with such a transplant, the patient had successful results: their heart function was strong and kidney performance stable, with no signs of rejection or serious infections over the first year. This is significant because it shows that a special treatment plan can make more organs available for transplantation, potentially saving lives. Who this helps: This helps patients waiting for heart and kidney transplants, especially those with complex immunological challenges.

PubMed

A 47-Year-Old Woman with Immunoglobulin G4 (IgG4)-Related Disease Involving the Right Ovary.

2020

The American journal of case reports

Alorjani MS, Obeidat NA, Ababneh EI, Salem AA, Matalka II

Plain English
This study looked at a 47-year-old woman diagnosed with a rare condition called IgG4-related disease that affected her right ovary. The tests showed her disease involved a complex ovarian cyst and revealed elevated IgG4 levels in her blood, meaning that 70% of her plasma cells were linked to this condition. This finding is important because it may help doctors recognize and understand ovarian involvement in IgG4-related disease better, potentially leading to clearer guidelines for diagnosis. Who this helps: This information helps doctors and patients who may be dealing with IgG4-related disease, especially regarding its rare effects on the ovaries.

PubMed

Glioblastoma and ABO blood groups: further evidence of an association between the distribution of blood group antigens and brain tumours.

2017

Blood transfusion = Trasfusione del sangue

Allouh MZ, Al Barbarawi MM, Hiasat MY, Al-Qaralleh MA, Ababneh EI

Plain English
This study looked at whether a person's blood type affects their chances of developing glioblastoma, a serious brain tumor. Researchers found that people with blood type A are 1.62 to 2.28 times more likely to get glioblastoma compared to those with blood type O, who have a lower risk. This matters because understanding these risks can help identify individuals who may need closer monitoring for this aggressive cancer. Who this helps: This helps patients and doctors by providing insight into glioblastoma risk factors.

PubMed

Frequent Co-Authors

William C Faquin Lakshmi Ganapathi Rory L Cochran Gregory K Robbins Sara Barmettler Steven M Holland Takayuki Yamamoto Daniel S Pearson Cynthia Harris Pitchaphon Nissaisorakarn

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.